Clinical Trial Update: Alternate-Day Buprenorphine Administration. Phase VIII - 9 [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating alternate-day buprenorphine administration for opioid use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Subutex (buprenorphine)
• buprenorphine (buprenorphine)

Snippet

Sponsor: University of Vermont | Conditions: Opioid-Related Disorders | Phase 2 | Status: COMPLETED